Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

PulmonX  (Stock symbol: LUNG )

700 Chesapeake Drive
Redwood City, CA 94063
USA
650.364.0400
Website Company Summary Management Team
Management

CEO: Glendon E French (12/18/2014)
President/COO/Operations: Steve Wallace (4/30/2009)
General Management: Jerome Erath (9/30/2016) ; Narinder Singh Shargill (9/30/2015)
Finance: Lauren Cristina (11/30/2013) ; Derrick Sung (5/10/2019) ; Martin Schneider (11/30/2013)
Technology: Sri Radhakrishnan (3/31/2013)
Sales/Marketing: David M Renzi ; Beran Rose ; Marcee Maroney
General Counsel/Legal: David Lehman
Company

Business description: Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.
Capital

Rounds: 8
Recent Fundings: May 2020   May 2019
Capital raised: 232.9M
Last Round: 66.0M
Ownership: Public   Ipo Filing
Stock Symbol: LUNG
VCs include: De Novo VenturesKleiner PerkinsMedVenture Associates;  Posco BioVentures;  Latterell Venture PartnersHealthCapMontreux Equity Partners;  Kaiser Permanente Foundation;  Adage Capital Management ;  Rock Springs Capital ;  Partner Fund Management ;  HealthQuest Capital
Private equity: Ally Bridge Group ;  ArrowMark Partners ;  RTW Investments ;  Driehaus Capital Management,

Last Tweets


 

Last Mentions


Overview
Record updated: May 2022
Sector: Medical
Year Founded: 1995
Headcount: 201-300 as of May 2022
Rounds: 8
Recent Fundings: May 2020   May 2019
Capital Raised: 232.9M
Last Round: 66.0M
Ownership: Public   Ipo Filing
Stock Symbol: LUNG